- In England, an estimated 54.9% of the population had Covid antibodies in the week to 28 March, the Office for National Statistics says
- That number was 49.1% in Wales, 54.5% in Northern Ireland and 46% in Scotland
- The US, South Africa and European Union pause the Johnson & Johnson vaccine rollout after reports of rare blood clotting
- The US Food and Drug Administration says six blood clot cases were detected after more than 6.8 million doses of the vaccine were administered
- Johnson & Johnson says that "no clear causal relationship" has been established between its vaccine and the clots
- A leading statistician says data supports PM Boris Johnson's claim lockdown, not vaccines, was the major cause of the UK's fall in cases
- A UK trial looking at whether different types of jabs can be used for first and second doses hopes to recruit more volunteers
- So far more than 32 million people in the UK have received a first vaccine dose, while 7.8 million have had both doses
Welcome to our daily rolling coverage of the coronavirus pandemic. We’ll bring you the latest updates throughout the day.
Here are the main headlines this morning:
- The US, South Africa and European Union will temporarily stop the rollout of the Johnson & Johnson Covid vaccine , after reports of rare blood clotting
- A major UK trial looking at whether Covid vaccines can be mixed with different types of jabs used for first and second doses is being expanded
- The family of a pregnant nurse who died with Covid-19 have yet to receive any money from a fundraising campaign that names them as beneficiaries
- Every adult in Fair Isle in Scotland, one of the UK's most remote communities, has now had a second vaccine dose
- Young black people have been hardest hit by unemployment during the pandemic, new research indicates
SummaryHere are the other key developments from the last few hours:
- People aged under 60 who have been given a first dose of the Oxford-AstraZeneca coronavirus vaccine in Germany will receive a different jab for their second dose, federal and regional health ministers agreed Tuesday. Germany announced on 30 March that it would no longer offer the two-dose AstraZeneca vaccine to people aged under 60 due to concerns over a possible link to rare cases of blood clots.
- Meanwhile India has again posted a national record number of new coronavirus cases, with 184,00 in a single day, according to the health ministry.
- The European Medicines Agency (EMA) said it was reviewing cases of rare blood clots in women who had taken Johnson & Johnson’s Covid-19 vaccine after US federal health authorities recommended pausing the use of the shot.
- Johnson & Johnson has made the decision to “proactively delay the rollout of our vaccine in Europe”, the company said.
- Canada said it had recorded its first case of blood clotting with low platelets after someone received the AstraZeneca Covid-19 vaccine, according to a health ministry statement. The person, who was not identified and who received the inoculation produced at the Serum Institute of India, is at home and recovering.
- Canada is to reinstate enhanced screening measures for travellers who have been in Brazil in the previous 14 days, Reuters reports.
- A Brazilian Supreme Court justice has ordered health regulator Anvisa to decide within 30 days whether it would approve the emergency import of Russia’s Sputnik V vaccine by the government of Maranhao state, Reuters reports.
- South Africa has temporarily suspended the rollout of Johnson & Johnson’s Covid-19 vaccine, its health minister said on Tuesday, after US federal health agencies recommended pausing its use because of rare cases of blood clots.
- Turkish president Tayyip Recep Erdogan announced several new restrictions and a “partial closure” for the first two weeks of the Islamic holy month of Ramadan to curb a rise in coronavirus infections.
Latest across Europe:
- The delay in rolling out the Johnson & Johnson vaccine is proving a headache for European governments that are relying on it to meet national vaccination targets.
- Spain’s vaccine programme has started slowly and it was expecting 5.5 million doses of the Janssen dose (as it is known in Europe) by the end of June. Belgium received its first delivery of the single-dose vaccine on Monday – it says it’ll wait for a “clear signal” from the EU’s medicines agency before deciding which age group will receive it. German immunology expert Carsten Watzl wants the government in Berlin to focus on securing other vaccine deliveries to ensure under-60s are inoculated.
- Lockdown in France has led to “significant and immediate health benefits” from a fall in pollution levels, according to the SPF public health agency. There has been an estimated fall of 2,300 deaths from exposure to particulate matter and another 1,200 from nitrogen dioxide linked to traffic.
- France has suspended fights to and from Brazil because of concerns surrounding the P-1 Covid-19 variant prevalent in the country. Two flights will arrive in France this morning which took off before the midnight ban came into force.
- Germany has reported more than 21,000 new infections in the past 24 hours and a rising seven-day incidence rate of 153.2.
- A Dutch programme to hold test events with audiences is to continue later this week with 1,500 people attending a music award festival in Utrecht. Further big events will take place on 24 April with audiences of 8,000 and 10,000. Everyone needs a negative test before the event and then five days afterwards too.
- In Croatia, Zagreb’s tourist board is offering half-price coronavirus tests to tourists who spend at least one night in the city. It wants them to extend their stay without worrying about their return home.